DETECTION OF SPECIFIC NITRATED MARKERS
    5.
    发明申请
    DETECTION OF SPECIFIC NITRATED MARKERS 有权
    检测特异性标记

    公开(公告)号:US20120010389A1

    公开(公告)日:2012-01-12

    申请号:US13221014

    申请日:2011-08-30

    IPC分类号: C07K16/00

    摘要: Methods are described for improving the diagnostic possibilities of diseases where oxidative NO-modifications occur, for example inflammatory conditions, cancer, Parkinson's or Alzheimer's disease, and to provide means of monitoring the effects of therapeutical measures taken towards such diseases. The invention enables the detection of disease specific catabolic markers related to oxidative NO-modifications, utilizing an immunoassay comprising antibodies directed against nitrated and non-nitrated epitopes characteristic of a specific protein.

    摘要翻译: 描述了用于改善发生氧化性NO-修饰的疾病的诊断可能性的方法,例如炎性病症,癌症,帕金森病或阿尔茨海默病,并提供监测对这些疾病采取的治疗措施的效果的方法。 本发明能够利用包含针对特异性蛋白特征性的硝化和非硝化表位的抗体的免疫测定来检测与氧化性NO修饰相关的疾病特异性分解代谢标志物。

    WATER-SOLUBLE STRONTIUM SALTS FOR USE IN TREATMENT OF CARTILAGE AND/OR BONE CONDITIONS
    6.
    发明申请
    WATER-SOLUBLE STRONTIUM SALTS FOR USE IN TREATMENT OF CARTILAGE AND/OR BONE CONDITIONS 失效
    用于治疗骨质疏松症和/或骨质疏松症的水溶性UM条

    公开(公告)号:US20100048697A1

    公开(公告)日:2010-02-25

    申请号:US12535053

    申请日:2009-08-04

    IPC分类号: A61K31/28

    摘要: Compounds and pharmaceutical compositions for use in the treatment and/or prophylaxis of cartilage and/or bone conditions and for methods of treating such condition. The compounds are salts of strontium that have a water-solubility of from about 1 g/l to about 100 g/l at room temperature, especially amino acid salts of strontium or dicarboxylic acid salts of strontium. Examples of novel water-soluble strontium salts are e.g. strontium glutamate and strontium alpha-ketoglutarate. The present invention also relates to an improved method for preparing the strontium salt of glutamic acid.

    摘要翻译: 用于治疗和/或预防软骨和/或骨骼状况的化合物和药物组合物以及治疗这种病症的方法。 化合物是在室温下具有约1g / l至约100g / l水溶性的锶盐,特别是锶的锶或二羧酸盐的氨基酸盐。 新的水溶性锶盐的实例是例如。 谷氨酸锶和α-酮戊二酸锶。 本发明还涉及一种制备谷氨酸锶盐的改进方法。

    Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions
    7.
    发明授权
    Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions 失效
    用于治疗软骨和/或骨骼状况的水溶性锶盐

    公开(公告)号:US07595342B2

    公开(公告)日:2009-09-29

    申请号:US11269289

    申请日:2005-11-07

    IPC分类号: A61K31/19

    摘要: Compounds and pharmaceutical compositions for use in the treatment and/or prophylaxis of cartilage and/or bone conditions and for methods of treating such condition. The compounds are salts of strontium that have a water-solubility of from about 1 g/l to about 100 g/l at room temperature, especially amino acid salts of strontium or dicarboxylic acid salts of strontium. Examples of novel water-soluble strontium salts are e.g. strontium glutamate and strontium alpha-ketoglutarate. The present invention also relates to an improved method for preparing the strontium salt of glutamic acid.

    摘要翻译: 用于治疗和/或预防软骨和/或骨骼状况的化合物和药物组合物以及治疗这种病症的方法。 化合物是在室温下具有约1g / l至约100g / l水溶性的锶盐,特别是锶的锶或二羧酸盐的氨基酸盐。 新的水溶性锶盐的实例是例如。 谷氨酸锶和α-酮戊二酸锶。 本发明还涉及一种制备谷氨酸锶盐的改进方法。